OverviewSuggest Edit

D3 Bio is a biotechnology company that develops medicines for oncology and immunology patients. It creates precision medicines that match therapies to the disease biomarkers of individual patients. The company aims to help convert life-threatening cancers into manageable chronic conditions.

TypePrivate
Founded2014
HQShangai, CN
Websited3bio.com

Latest Updates

Cybersecurity ratingAMore

Key People/Management at D3 Bio

George Chen

George Chen

Chairman and CEO

D3 Bio Office Locations

D3 Bio has an office in Shangai
Shangai, CN (HQ)
Shang'ai, Jinxian County
Show all (1)

D3 Bio Financials and Metrics

Summary Metrics

Founding Date

2014

D3 Bio total Funding

$200 m

D3 Bio latest funding size

$200 m

Time since last funding

9 months ago

D3 Bio investors

D3 Bio's latest funding round in November 2020 was reported to be $200 m. In total, D3 Bio has raised $200 m
Show all financial metrics

D3 Bio Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

D3 Bio Online and Social Media Presence

Embed Graph

D3 Bio News and Updates

D3 Bio Raises US$200M in Series A Financing

D3 Bio, a Shangai, China-based global biotechnology company focused on developing and commercializing precision medicines to improve or replace existing standard-of-care treatments that do not fully meet patient needs, launched today with US$200m in Series A financing

D3 Bio Frequently Asked Questions

  • When was D3 Bio founded?

    D3 Bio was founded in 2014.

  • Who are D3 Bio key executives?

    D3 Bio's key executives are George Chen.

  • Who are D3 Bio competitors?

    Competitors of D3 Bio include Exelixis, CureVac and Nektar Therapeutics.

  • Where is D3 Bio headquarters?

    D3 Bio headquarters is located at Shang'ai, Jinxian County, Shangai.

  • Where are D3 Bio offices?

    D3 Bio has an office in Shangai.

  • How many offices does D3 Bio have?

    D3 Bio has 1 office.